Fig. 3From: Identification of predictive biomarkers for endometrial cancer diagnosis and treatment response monitoring using plasma metabolome profilingA Receiver operating characteristic curve showing the true vs. the false positive rate for a model based on the top 5 to 100 metabolites, used for evaluating the sensitivity and specificity of each metabolite for EMC. The vertical axis of the plot shows sensitivity (true positive rate) and the horizontal axis shows 1-specificity (false positive rate). B Metabolites with significant top 5 contributions in the ROC curve. Blue and red bars indicate decreased and increased levels in patients with EMC, respectively, relative to healthy controls. C Box plots of metabolites with the top five largest contributions in the ROC curve. *P < 0.05 compared with cohortBack to article page